Chris Eichman
1 Papers
Chris Eichman is an academic researcher. The author has contributed to research in topics: Receptor & Jurkat cells. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
John Emery,Peter C. McDonnell,Michael Brigham Burke,Keith Charles Deen,Sally D. Lyn,Carol Silverman,Edward Dul,Appelbaum Edward Robert,Chris Eichman,Rocco DiPrinzio,R.A. Dodds,Ian E. James,Martin Rosenberg,John C. Lee,Peter Young +14 more
TL;DR: A fifth TRAIL receptor is identified, namely osteoprotegerin (OPG), a secreted tumor necrosis factor receptor homologue that inhibits osteoclastogenesis and increases bone density in vivo and is suggested to suggest potential cross-regulatory mechanisms by OPG and TRAIL.
1.3K